| Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart … AP Maggioni, SD Anker, U Dahlström, G Filippatos, P Ponikowski, ... European journal of heart failure 15 (10), 1173-1184, 2013 | 800 | 2013 |
| European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions MG Crespo‐Leiro, SD Anker, AP Maggioni, AJ Coats, G Filippatos, ... European journal of heart failure 18 (6), 613-625, 2016 | 720 | 2016 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 259 | 2019 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 238 | 2019 |
| Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up … MG Crespo-Leiro, SD Anker, AP Maggioni, AJ Coats, G Filippatos, ... Eur J Heart Fail 18 (6), 613-25, 2016 | 221 | 2016 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 198 | 2019 |
| In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ... European journal of heart failure 19 (1), 54-65, 2017 | 168 | 2017 |
| Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ... JACC: Heart Failure 6 (6), 452-462, 2018 | 139 | 2018 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 111 | 2020 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 91 | 2020 |
| A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 24 (2), 335-350, 2022 | 63 | 2022 |
| Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry CJ Kapelios, C Laroche, MG Crespo‐Leiro, SD Anker, AJS Coats, ... European journal of heart failure 22 (8), 1424-1437, 2020 | 47 | 2020 |
| Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration … CJ Kapelios, M Lainscak, G Savarese, C Laroche, P Seferovic, ... European journal of heart failure 21 (11), 1383-1397, 2019 | 43 | 2019 |
| Heart Failure Association (HFA) of the European Society of Cardiology (ESC) MG Crespo‐Leiro, SD Anker, AP Maggioni, AJ Coats, G Filippatos, ... European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT) 1, 0 | 43 | |
| Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 24 | 2021 |
| Erythropoietin in cardiorenal anemia syndrome E Fazlibegović, M Hadžiomerović, S Ćorić, E Babić, F Fazlibegović Bosnian Journal of Basic Medical Sciences 6 (4), 36, 2006 | 9 | 2006 |
| EFFECTS OF NEBIVOLOL ON ARTERY HYPERTENSIONMULTICENTRE STUDY BOSNIA AND HERZEGOVINA K Divković, F Baraković, E Smajić, A Arslanagić, M Hadžiomerović, ... Bosnian Journal of Basic Medical Sciences 5 (1), 42, 2005 | 9 | 2005 |
| Analizing Recent Trends in Coronary Heart Disease (CHD) Deaths Among the Elderly in the United States Using Data From Official Statistical Sources E Veledar, R Fazel, L Shaw, E Fazlibegovic, M Hadziomerovic Medical Archives 64 (5), 281, 2010 | 8 | 2010 |
| Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in‐hospital and long‐term outcomes–from the ESC‐HFA EORP Heart … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 25 (9), 1571-1583, 2023 | 6 | 2023 |
| SCD in the world, Europe, Bosnia and Herzegovina and Mostar. E Fazlibegovic, M Hadziomerovic, A Dedovic, E Veledar, F Fazlibegovic Medicinski arhiv 61 (2 Suppl 1), 23-26, 2007 | 6 | 2007 |
